Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Assurex Health (United States)
Alternate name:
Assurex Health, Inc.
ROR:
02jdgc236
OpenAlex ID:
I4405271525
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
2019
·
John F. Greden
, Sagar V. Parikh
, et al.
·
Journal of Psychiatric Research
·
360
PDF
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
2013
·
Daniel K. Hall-Flavin
, Joel G. Winner
, et al.
·
Pharmacogenetics and Genomics
·
215
Using a pharmacogenomic algorithm to guide the treatment of depression
2012
·
D K Hall-Flavin
, J G Winner
, et al.
·
Translational Psychiatry
·
188
PDF
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
2013
·
Joel G Winner
, Joseph M Carhart
, et al.
·
PubMed
·
164
Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation
2015
·
Joel G. Winner
, Joseph M. Carhart
, et al.
·
Current Medical Research and Opinion
·
140
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
2013
·
J Winner
, J D Allen
, et al.
·
Translational Psychiatry
·
128
PDF
Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes
2015
·
C A Altar
, J M Carhart
, et al.
·
The Pharmacogenomics Journal
·
117
Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy
2013
·
C. Anthony Altar
, John Hornberger
, et al.
·
International Review of Psychiatry
·
88
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
2018
·
Duan Liu
, Balmiki Ray
, et al.
·
Translational Psychiatry
·
83
PDF
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial
2019
·
Michael E. Thase
, Sagar V. Parikh
, et al.
·
The Journal of Clinical Psychiatry
·
77
PDF
Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain–gut axis
2015
·
J. W. Wiley
, G. A. Higgins
, et al.
·
Neurogastroenterology & Motility
·
66
PDF
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting
2017
·
Lisa C. Brown
, Raymond A. Lorenz
, et al.
·
Clinical Therapeutics
·
65
PDF
Preservation of Biospecimens at Ambient Temperature: Special Focus on Nucleic Acids and Opportunities for the Biobanking Community
2016
·
Rolf Muller
, Fay Betsou
, et al.
·
Biopreservation and Biobanking
·
48
A Glutamatergic Network Mediates Lithium Response in Bipolar Disorder as Defined by Epigenome Pathway Analysis
2015
·
Gerald A Higgins
, Ari Allyn-Feuer
, et al.
·
Pharmacogenomics
·
46
Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial
2019
·
Boadie W. Dunlop
, Sagar V. Parikh
, et al.
·
BMC Psychiatry
·
41
PDF
Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists
2018
·
Julie-Anne Tanner
, Paige E. Davies
, et al.
·
Journal of Psychiatric Research
·
40
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
2020
·
Brent P. Forester
, Sagar V. Parikh
, et al.
·
American Journal of Geriatric Psychiatry
·
38
PDF
Analytical Validation of a Psychiatric Pharmacogenomic Test
2018
·
Michael R Jablonski
, Nina King
, et al.
·
Personalized Medicine
·
34
PDF
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate
2018
·
Richard C. Crist
, James Li
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
32
CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels
2018
·
Balmiki Ray
, Eren Ozcagli
, et al.
·
Pharmacogenetics and Genomics
·
27
Epigenomic Mapping and Effect Sizes of Noncoding Variants Associated with Psychotropic Drug Response
2015
·
Gerald A Higgins
, Ari Allyn-Feuer
, et al.
·
Pharmacogenomics
·
23
PDF
Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility.
2015
·
Joel G Winner
, Bryan Dechairo
·
PubMed Central
·
21
PDF
The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes
2015
·
Joachim Benitez
, Michael R. Jablonski
, et al.
·
Applied & Translational Genomics
·
18
Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
2019
·
Julie-Anne Tanner
, Lisa C Brown
, et al.
·
ClinicoEconomics and Outcomes Research
·
15
PDF
The Epigenome, 4D Nucleome and Next-Generation Neuropsychiatric Pharmacogenomics
2015
·
Gerald A Higgins
, Ari Allyn-Feuer
, et al.
·
Pharmacogenomics
·
14
PDF
Show more works
View as search
Works count:
40
Citation count:
6,298
Year
Topic
Type
